Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement. - Muhsen IN; Roloff GW; Faramand R; Othman T; Valtis Y; Kopmar NE; Dekker SE; Connor M; Mercadal S; O'Connor TE; Dykes KC; Ahmed M; et al. (Blood advances, 2025)